FDA Inspection 1008038 — Montefiore's Institute for Reproductive Medicine and Health
The FDA completed an inspection of Montefiore's Institute for Reproductive Medicine and Health on March 22, 2017 in Hartsdale, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hartsdale, NY (United States)